Diabetes mellitus and colorectal cancer prognosis: A meta-analysis

Diseases of the Colon and Rectum

Volumn 56, Issue 11, 2013, Pages 1304-1319

  Mills, Katherine T ^a   Bellows, Charles F ^b   Hoffman, Aaron E ^a   Kelly, Tanika N ^a   Gagliardi, Giuseppe ^b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal neoplasms; Colorectal neoplasms metabolism; Colorectal neoplasms prognosis; Diabetes mellitus; Meta analysis

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS;

COLORECTAL NEOPLASMS; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 84888350067     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e3182a479f9     Document Type: Article

References (62)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Available at: http://globocan. iarc.fr. Accessed December 17, 2012.
2. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:s836-s842.
3. Berster JM, Göke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem. 2008;114: 84-98.
4. Aleksandrova K, Boeing H, Jenab M, et al. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev Res (Phila). 2011;4: 1873-1883.
5. Danaei G, Finucane MM, Lu Y, et al Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378: 31-40.
6. National Cancer Institute. SER Stat Fact Sheets: Colon and Rectum. Available at: http://seer.cancer.gov/statfacts/html/colorect. html. Accessed December 17, 2012.
7. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg. 2002;6: 88-94.
8. Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21: 433-440.
9. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54: 1898-1904.
10. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24: 5017-5024.
11. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol. 1998;147: 816-825.
12. Polendak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006;30: 466-472.
13. Huang YC, Lin JK, Chen WS, et al. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol. 2011;137: 211-220.
14. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K. The impact of type 2 diabetes mellitus on cancer-specific survival: a followup study in Sweden. Cancer. 2012;118: 1353-1361.
15. Stein KB, Snyder CF, Barone BB, et al. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci. 2010;55: 1839-1851.
16. Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study- II Nutrition Cohort. J Clin Oncol. 2012;30: 53-59.
17. Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med. 2006;145: 646-653.
18. Payne JE, Meyer HJ. The influence of other diseases upon the outcome of colorectal cancer patients. Aust N Z J Surg. 1995;65: 398-402.
19. Lai CC, You JF, Yeh CY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011;26: 473-481.
20. van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE. Disease-specific mortality among stage I-II colorectal cancer patients with diabetes: a large populationbased analysis. Diabetologia. 2012;55: 2163-2172.
21. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61: 344-349.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7: 177-188.
23. Sarfati D, Hill S, Blakely T, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer. 2009;9:116.
24. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92: 615-623.
25. Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer. 2007;43: 2179-2193.
26. Maas HA, Lemmens VE, Cox S, et al. The effects of age and comorbidity on treatment patterns of radiotherapy and survival in patients with mobile rectal cancer: a population-based study. Euro Geriatr Med. 2011;2: 273-279.
27. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120: 1986-1992.
28. Zhou ZG, Pan ZZ, Wan DS, et al. Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy [in Chinese]. Ai Zheng. 2009;28: 908-912.
29. Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117: 1957-1965.
30. Chen CQ, Fang LK, Cai SR, et al. Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl). 2010;123: 3084-3088.
31. Chiao EY, Nambi PV, Naik AD. The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv. 2010;4: 381-387.
32. Feng JF, Zhou XM, Mao WM. Prognostic analysis of colorectal cancer patients with diabetes mellitus in China: the experience of a single institution. Adv Clin Exp Med. 2011;20: 473-480.
33. Gao RZ, Gu J, Du CZ, Li M. Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer [in Chinese]. Zhonghua Wai Ke Za Zhi. 2010;48: 88-92.
34. Huang CW, Sun LC, Shih YL, et al. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer. World J Surg Oncol. 2012;10:76.
35. Jullumstrø E, Kollind M, Lydersen S, Edna TH. Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol. 2009;48: 361-367.
36. Noh GY, Hwang DY, Choi YH, Lee YY. Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol. 2010;26: 424-428.
37. Sarfati D, Tan L, Blakely T, Pearce N. Comorbidity among patients with colon cancer in New Zealand. N Z Med J. 2011;124: 76-88.
38. Shonka NA, Anderson JR, Panwalkar AW, Reed EC, Steen PD, Ganti AK. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006;23: 515-519.
39. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008;53: 2486-2494.
40. Tiwana J, Ortman S, Davies T, et al. Long-standing diabetes and its effects on outcomes in colon cancer. J Clin Oncol. 2011;29: e14019.
41. Zhou ZG, Wu XJ, Li LR, et al. A multivariate analysis of prognostic determinants for stages II and II colorectal cancer in 141 patients. Chin Med J (Engl). 2011;124: 2132-2135.
42. Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care. 2012;35: 113-118.
43. McBean AM, Yu X. The underuse of screening services among elderly women with diabetes. Diabetes Care. 2007;30: 1466-1472.
44. Gross CP, McAvay GJ, Guo Z, Tinetti ME. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer. 2007;109: 2410-2419.
45. Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EA, Møller H; Diabetes and Cancer Research Consortium. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia. 2012;55: 1619-1632.
46. Caudle AS, Kim HJ, Tepper JE, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15: 1931-1936.
47. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut. 2006;55: 285-291.
48. Richardson LC, Pollack LA. Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol. 2005;2: 48-53.
49. Wolpin BM, Meyerhardt JA, Chan AT, et al. Insulin, the insulinlike growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009;27: 176-185.
50. Fuchs CS, Goldberg RM, Sargent DJ, et al. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clin Cancer Res. 2008;14: 8263-8269.
51. Haydon AM, Macinnis RJ, English DR, Morris H, Giles GG. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut. 2006;55: 689-694.
52. Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009;32: 1620-1625.
53. Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2010;3: 1451-1461.
54. Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, Kim WH. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer. 2012;131: 752-759.
55. Garrett CR, Hassabo HM, Bhadkamkar NA, et al. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Br J Cancer. 2012;106: 1374-1378.
56. Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310: 1642-1646.
57. Bonanni B, Puntoni M, Cazzaniga M, et al. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol. 2012;30: 2593-2600.
58. Rattan R, Ali Fehmi R, Munkarah A. Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis. J Oncol. 2012;2012:928127.
59. Meyerhardt JA, Sato K, Niedzwiecki D, et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012;104: 1702-1711.
60. Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol. 2013;31: 876-885.
61. DeCensi A, Gennari A. Insulin breast cancer connection: confirmatory data set the stage for better care. J Clin Oncol. 2011;29: 7-10.
62. Li C, Zhao G, Okoro CA, Wen XJ, Ford ES, Balluz LS. Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among U.S. adults with diagnosed diabetes: findings from the 2009 Behavioral Risk Factor Surveillance System. Diabetes Care. 2013;36: 1569-1576.